imexon imexon imexon (inn, trade name amplimexon) is a substance that is being studied in the treatment of some types of cancer, including pancreatic, lung, breast, prostate, melanoma, and multiple myeloma. it is a cyanoaziridine derivative. imexonclinical dataatc codenoneidentifiers iupac name 4-imino-1,3-diazabicyclohexan-2-one cas number59643-91-3 ypubchem cid68791chemspider62031 nunii8f63u28t2vkeggd08932 ycomptox dashboard (epa)dtxsid1046895 echa infocard100.056.199 chemical and physical dataformulac4h5n3omolar mass111.104 g·mol−13d model (jsmol)interactive image smiles o=c1/n=c(/n)c2n1c2 inchi inchi=1s/c4h5n3o/c5-3-2-1-7(2)4(8)6-3/h2h,1h2,(h2,5,6,8) nkey:bixbbiptybjtry-uhfffaoysa-n n ny (what is this?) (verify)